This page is optimized for a taller screen. Please rotate your device or increase the size of your browser window.

Maternal Opioid Misuse (MOM) Model Evaluation - Pre-Implementation Evaluation Report

Katharine Witgert, Abt Global; Dominick Esposito, Lois Simon, Meg Tucker, Jordan Stangle, and Terry Moore, Insight Policy Research; and Ian Hill, Brigette Courtot, and Emily Burroughs, Urban Institute


February 23, 2022

The Maternal Opioid Misuse (MOM) Model is a Center for Medicare and Medicaid Services (CMS) patient-centered service-delivery model. The purpose of the model is to improve the quality of care and reduce costs for pregnant and postpartum Medicaid beneficiaries with opioid use disorder (OUD) and their infants through state-driven care transformation. 

The MOM Model is part of the CMS Innovation Center’s multipronged strategy to combat the Nation’s opioid crisis as rates of OUD and opioid-related overdose deaths in America have rapidly increased over the last 10 years, especially among pregnant and parenting people. Abt Global is part of the team evaluating MOM.

The findings include:

  • Nearly every MOM awardee state had either already implemented or planned to implement a policy to extend postpartum coverage for Medicaid beneficiaries through 12 months.
  • Interviewees consistently identified societal stigma against pregnant and parenting people with OUD as a primary barrier to seeking help.

Overall, interviewees identified numerous potential psychosocial and physical barriers to care and described the personal strengths, community resources, and treatment team support that help overcome barriers to recovery. Learn more about this project.

Full Report: MOM Model Pre-Implementation Evaluation Report

Summary: MOM Model Pre-Implementation Evaluation Report - Findings At A Glance